Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Amgen Really as Cheap as It Looks?

TheMotleyFool

0 0

Is Amgen Really as Cheap as It Looks?Photo, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

You might have run across headlines in recent months about how Amgen (NASDAQ: AMGN) is too cheap of a stock to ignore. I've seen several articles that trumpeted the big biotech's attractive valuation.

If you look at Amgen's forward price-to-earnings (P/E) ratio of 12.4, the stock indeed does appear to be trading at an appealing valuation. But is Amgen really as cheap as it looks? I don't think so.

Image source: Getty Images.

Source Fool.com

Like: 0

AMGN

Share